Macquarie Upgrades XPeng (XPEV) to Outperform

On May 22, Macquarie upgraded its classification on Xpeng Inc. (NYSE: XPEV) from neutral to superiority, and raising the target price from $ 22 to $ 24.

MacQuarie eugeneo eugeneo made this upgrade after the powerful Xpeng report Q1 2025, another quarter that leads the company towards a net profit. Over the past seven seven seven, the XPENG total margin has improved, with the first quarter margin to be reported by 15.6 %. During the first quarter, the company reduced its losses from $ 190 million in the same quarter of last year to about 91.6 billion dollars. HSIAO said that the company’s profitability’s goal appears to be clear with standard delivery operations during the quarter. The Xpeng management expects the company to be profitable by the fourth quarter of 2025.

The assembly line of electric cars move along the production line.

The company completed the delivery of 94,008 vehicles during the first quarter. The company’s revenues amounted to about 2.20 billion dollars, exceeding 17.42 million dollars. Xpeng vehicle sales revenue increased more than 159 % over the past year, reducing the inconsistent losses compared to last year.

HSIAO added that Xpeng Inc. (NYSE: XPEV) now covers its previous challenges. The analyst believes that the Chinese EV SMART maker can “start a growth cycle” through M03 and P7+ compounds, and restore their share on the EV market. Xpeng has announced the launch of the 2025 G6, G9 and Mona Max models, while the company expects to start the G7 and the latest P7 models in Q3.

Xpeng Inc. (NYSE: XPEV) is a well -known Chinese SMART EV manufacturer. It works in smart EVS design, production and marketing. The famous Xpeng vehicles include the SUV (G3) and a four -door sports sedan (P7). The company mainly targets the Mediterranean EV sector to the advanced in the passenger vehicle market in China.

Although we acknowledge the possibility of XPEV, our condemnation lies in the belief that some of Amnesty International’s shares are returning more promises to make higher and limited returns than negative risks. If you are looking for a more promising IQ stock of XPEV and has 100x capabilities, check our report on this topic The cheapest inventory of artificial intelligence.

Read the following: 30 best shares for purchase now according to billionaires and 15 stocks of small health care that the hedge is purchased.

Detection. no one.